Hypodermic needles are hollow, cylindrical needles with a puncture point at the pointed tip, which are attached to hypodermic syringes. These needles are used to inject solutions through subcutaneous, intravenous, and intramuscular modes for rapid uptake of substances (insulin, vaccines, and others) that are not readily absorbed in the body. These needles are also used to extract body fluids for diagnosis.... Research Beam Model: Research Beam Product ID: 1548268 5370 USD New
Global Hypodermic Needles Market by Product Type {Safety Hypodermic Needles, by Type (Retractable Needles, Non-retractable Needles) and Safety Hypodermic Needles, by Mode of Activation (Active Needles and Passive Needles), Non-Safety Hypodermic Needles}, Application (Drug Delivery, Vaccination, and Blood Specimen Collection), End User (Hospitals, Diabetic Patients, Family Practices, Psychiatrics, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022
 

Global Hypodermic Needles Market by Product Type {Safety Hypodermic Needles, by Type (Retractable Needles, Non-retractable Needles) and Safety Hypodermic Needles, by Mode of Activation (Active Needles and Passive Needles), Non-Safety Hypodermic Needles}, Application (Drug Delivery, Vaccination, and Blood Specimen Collection), End User (Hospitals, Diabetic Patients, Family Practices, Psychiatrics, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Global Hypodermic Needles Market by Product Type {Safety Hypodermic Needles, by Type (Retractable Needles, Non-retractable Needles) and Safety Hypoder

Category : Healthcare
Published On : May  2017
Pages : 162

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Hypodermic needles are hollow, cylindrical needles with a puncture point at the pointed tip, which are attached to hypodermic syringes. These needles are used to inject solutions through subcutaneous, intravenous, and intramuscular modes for rapid uptake of substances (insulin, vaccines, and others) that are not readily absorbed in the body. These needles are also used to extract body fluids for diagnosis.

Increase in incidence of needle stick injuries, implementation of stringent compliance for using safety needles, and surge in demand for injectable drugs & vaccines drive the market. In addition, rise in incidence of chronic and lifestyle diseases, especially diabetes supplement the market growth. However, availability of alternative modes of drug delivery, unawareness regarding safety syringes, and high cost of hypodermic needles hamper the market growth. Furthermore, the untapped emerging economies present lucrative opportunities for the market. The global hypodermic needles market accounted for $2,396 million in 2015, and is anticipated to reach $3,842 million by 2022, registering a CAGR of 6.9% from 2016 to 2022

The global hypodermic needles market is segmented based on product type, applications, end user, and geography both in terms of both value and volume. Based on product type, the market is bifurcated into safety and non-safety hypodermic needles. The safety hypodermic needles segment is further classified based on type and mode of activation. Based on type, safety hypodermic needles are divided into retractable and non-retractable needles. Based on the mode of activation, safety hypodermic needles are classified into active and passive hypodermic needles. The safety hypodermic needle holds the largest market share, owing to the technological advancements (retractable & passive needles and others), prevention of needle-stick injuries and safety mechanisms embedded in these needles. Based on application, this market is categorized into drug delivery, vaccination, and blood specimen collection. The drug delivery application was the highest revenue contributor in 2015, while the vaccination segment is anticipated to grow at the highest rate. The growth for this segment is due to the high birth rates and awareness regarding vaccination throughout the world.

Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the hypodermic needles market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the higher buying power and stringent regulations that favor the utilization of hypodermic needles in this region. There is also increased awareness regarding the risk of cross infection (such as Hepatitis, HIV, and AIDS) and needle stick injuries in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.

Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global hypodermic needles market.

KEY MARKET BENEFITS

  • The study provides an in-depth analysis of the global hypodermic needles market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market for the period of 2014-2022 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product type assists in understanding the trends in the industry.
  • Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Product Type

  • Safety Hypodermic Needles, by Type
    • Retractable
    • Non-retractable
  • Safety Hypodermic Needles, by Mode of Activation
    • Active Hypodermic Needles
    • Passive Hypodermic Needles
  • Non-Safety Hypodermic Needles

By Application

  • Drug Delivery
  • Vaccination
  • Blood Specimen Collection

By End User

  • Hospitals
  • Diabetic Patients
  • Family Practices
  • Psychiatrics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Indonesia
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Venezuela
    • Saudi Arabia
    • South Africa
    • Colombia
    • Argentina
    • Rest of LAMEA

KEY PLAYERS PROFILED

  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Catalent, Inc.
  • Connecticut Hypodermics, Inc.
  • EXELINT International Co.
  • MedPro Safety Products, Inc.
  • Medtronic plc,
  • Retractable Technologies, Inc.
  • Smiths Group plc,
  • Terumo Medical Corporation.

Other players in the value chain include (profiles not included in the report)

  • Albert David
  • DeRoyal
  • Hindustan Syringes & Medical Devices Limited
  • Hi-Tech Syringes
  • International Medsurg Connection
  • Medline Industries, Inc
  • Nipro Medical Corporation
  • Unilife Corporation
  • Vita Needle Company
  • Vygon

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. GOVERNMENT REGULATIONS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rise in number of needle-stick injuries
3.5.1.2. Increase in consumption of injectable drugs and vaccines
3.5.1.3. Active Government initiatives
3.5.1.1. Surge in application of injection and infusion therapies

3.5.2. Restraints

3.5.2.1. High cost of safety hypodermic needles
3.5.2.2. Alternative modes of drug delivery
3.5.2.3. Limited awareness of hypodermic needles in emerging economies

3.5.3. Opportunities

3.5.3.1. High prevalence of blood borne diseases
3.5.3.2. Lucrative opportunities in emerging economies

CHAPTER 4 HYPODERMIC NEEDLES MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SAFETY HYPODERMIC NEEDLES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Safety Hypodermic needles, by type

4.2.4.1. Market size and forecast
4.2.4.2. Retractable safety hypodermic needles

4.2.4.2.1. Market size and forecast

4.2.4.3. Non-retractable safety hypodermic needles

4.2.4.3.1. Market size and forecast

4.2.5. Safety Hypodermic needles, by Mode of Activation

4.2.5.1. Market size and forecast
4.2.5.2. Active Safety Hypodermic Needles

4.2.5.2.1. Market size and Forecast

4.2.5.3. Passive Safety Hypodermic Needles

4.2.5.3.1. Market size and Forecast

4.3. NON-SAFETY HYPODERMIC NEEDLES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 HYPODERMIC NEEDLES MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DRUG DELIVERY

5.2.1. Market size and forecast

5.3. VACCINATION

5.3.1. Market size and forecast

5.4. BLOOD SPECIMEN COLLECTION

5.4.1. Market size and forecast

CHAPTER 6 HYPODERMIC NEEDLES MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. DIABETIC PATIENTS

6.3.1. Market size and forecast

6.4. FAMILY PRACTICES

6.4.1. Market size and forecast

6.5. PSYCHIATRICS

6.5.1. Market size and Forecast

6.6. OTHERS

6.6.1. Market size and forecast

CHAPTER 7 HYPODERMIC NEEDLES MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Russia market size and forecast
7.3.3.7. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Indonesia market size and forecast
7.4.3.8. Thailand market size and forecast
7.4.3.9. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Venezuela market size and forecast
7.5.3.4. Saudi Arabia market size and forecast
7.5.3.5. South Africa market size and forecast
7.5.3.6. Colombia market size and forecast
7.5.3.7. Argentina market size and forecast
7.5.3.8. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. BECTON, DICKINSON AND COMPANY

8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves & developments

8.2. B. BRAUN MELSUNGEN AG

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategies and developments

8.3. CATALENT, INC.

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance

8.4. CONNECTICUT HYPODERMICS INC.

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance

8.5. EXELINT INTERNATIONAL CO.

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance

8.6. MEDPRO SAFETY PRODUCTS, INC.

8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Business performance

8.7. MEDTRONIC PLC

8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Business performance

8.8. RETRACTABLE TECHNOLOGIES, INC.

8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Business performance

8.9. SMITHS GROUP PLC

8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Business performance

8.10. TERUMO MEDICAL CORPORATION

8.10.1. Company overview
8.10.2. Business performance

LIST OF TABLES

TABLE 1. GLOBAL HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 2. GLOBAL HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 (MILLION UNITS)
TABLE 3. GLOBAL SAFETY HYPODERMIC NEEDLE MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 4. GLOBAL SAFETY HYPODERMIC NEEDLE MARKET, BY PRODUCT TYPE, 2014-2022 (MILLION UNITS)
TABLE 5. GLOBAL SAFETY HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 6. GLOBAL SAFETY HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 7. GLOBAL SAFETY HYPODERMIC NEEDLE MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 8. GLOBAL SAFETY HYPODERMIC NEEDLE MARKET, BY TYPE, 2014-2022 (MILLION UNITS)
TABLE 9. RETRACTABLE SAFETY HYPODERMIC NEEDLES, KEY PRODUCTS
TABLE 10. GLOBAL RETRACTABLE SAFETY HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 11. GLOBAL RETRACTABLE SAFETY HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 12. GLOBAL NON-RETRACTABLE SAFETY HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 13. GLOBAL NON-RETRACTABLE SAFETY HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 14. GLOBAL SAFETY HYPODERMIC NEEDLE MARKET, BY MODE OF ACTIVATION, 2014-2022 ($MILLION)
TABLE 15. GLOBAL SAFETY HYPODERMIC NEEDLE MARKET, BY MODE OF ACTIVATION, 2014-2022 (MILLION UNITS)
TABLE 16. GLOBAL ACTIVE SAFETY HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 17. GLOBAL ACTIVE SAFETY HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 18. GLOBAL PASSIVE SAFETY HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 19. GLOBAL PASSIVE SAFETY HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 20. NON-SAFETY HYPODERMIC NEEDLES, KEY PRODUCTS
TABLE 21. GLOBAL NON-SAFETY HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 22. GLOBAL NON-SAFETY HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 23. GLOBAL HYPODERMIC NEEDLES MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 24. GLOBAL HYPODERMIC NEEDLES MARKET, BY APPLICATION, 2014-2022 (MILLION UNITS)
TABLE 25. GLOBAL DRUG DELIVERY HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 26. GLOBAL DRUG DELIVERY HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 27. GLOBAL VACCINATION HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 28. GLOBAL VACCINATION HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 29. GLOBAL BLOOD SPECIMEN COLLECTION HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 30. GLOBAL BLOOD SPECIMEN COLLECTION HYPODERMIC NEEDLE MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 31. GLOBAL HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 32. GLOBAL HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 (MILLION UNITS)
TABLE 33. DIABETIC PATIENTS HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 34. DIABETIC PATIENTS HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 35. FAMILY PRACTICES HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 36. FAMILY PRACTICES HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 37. PSYCHIATRICS HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 38. PSYCHIATRICS HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 39. OTHER END USER HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 40. OTHER END USER HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 41. HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 42. HYPODERMIC NEEDLES MARKET, BY REGION, 2014-2022 (MILLION UNITS)
TABLE 43. NORTH AMERICA HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 44. NORTH AMERICA HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2014-2022 (MILLION UNITS)
TABLE 45. NORTH AMERICA HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 46. NORTH AMERICA HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 (MILLION UNITS)
TABLE 47. NORTH AMERICA HYPODERMIC NEEDLES MARKET, BY APPLICATION 2014-2022 ($MILLION)
TABLE 48. NORTH AMERICA HYPODERMIC NEEDLES MARKET, BY APPLICATION 2014-2022 (MILLION UNITS)
TABLE 49. NORTH AMERICA HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 50. NORTH AMERICA HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 (MILLION UNITS)
TABLE 51. EUROPE HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 52. EUROPE HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2014-2022 (MILLION UNITS)
TABLE 53. EUROPE HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 54. EUROPE HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 (MILLION UNITS)
TABLE 55. EUROPE HYPODERMIC NEEDLES MARKET, BY APPLICATION 2014-2022 ($MILLION)
TABLE 56. EUROPE HYPODERMIC NEEDLES MARKET, BY APPLICATION 2014-2022 (MILLION UNITS)
TABLE 57. EUROPE HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 58. EUROPE HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 (MILLION UNITS)
TABLE 59. ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 60. ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2014-2022 (MILLION UNITS)
TABLE 61. ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 62. ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 (MILLION UNITS)
TABLE 63. ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, BY APPLICATION 2014-2022 ($MILLION)
TABLE 64. ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, BY APPLICATION 2014-2022 (MILLION UNITS)
TABLE 65. ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 66. ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 (MILLION UNITS)
TABLE 67. LAMEA HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 68. LAMEA HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2014-2022 (MILLION UNITS)
TABLE 69. LAMEA HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 70. LAMEA HYPODERMIC NEEDLES MARKET, BY PRODUCT, 2014-2022 (MILLION UNITS)
TABLE 71. LAMEA HYPODERMIC NEEDLES MARKET, BY APPLICATION 2014-2022 ($MILLION)
TABLE 72. LAMEA HYPODERMIC NEEDLES MARKET, BY APPLICATION 2014-2022 (MILLION UNITS)
TABLE 73. LAMEA HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 74. LAMEA HYPODERMIC NEEDLES MARKET, BY END USER, 2014-2022 (MILLION UNITS)
TABLE 75. BD: COMPANY SNAPSHOT
TABLE 76. B BRAUN: COMPANY SNAPSHOT
TABLE 77. CATALENT: COMPANY SNAPSHOT
TABLE 78. CONNECTICUT: COMPANY SNAPSHOT
TABLE 79. EXELINT: COMPANY SNAPSHOT
TABLE 80. MEDPRO: COMPANY SNAPSHOT
TABLE 81. MEDTRONIC: COMPANY SNAPSHOT
TABLE 82. RETRACTABLE: COMPANY SNAPSHOT
TABLE 83. SMITHS: COMPANY SNAPSHOT
TABLE 84. TERUMO: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. GLOBAL HYPODERMIC NEEDLES MARKET, 2014-2022
FIGURE 2. SNAPSHOT OF GLOBAL HYPODERMIC NEEDLES MARKET
FIGURE 3. SEGMENTATION OF GLOBAL HYPODERMIC NEEDLES MARKET
FIGURE 4. TOP INVESTMENT POCKETS IN GLOBAL HYPODERMIC NEEDLES MARKET
FIGURE 5. TOP WINNING STRATEGIES: TYPE AND COMPANY
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. RESTRAINTS AND DRIVERS: GLOBAL HYPODERMIC NEEDLES MARKET
FIGURE 12. GLOBAL HYPODERMIC NEEDLES MARKET: PRODUCT SEGMENTATION
FIGURE 13. U.S. HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 14. U.S. HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 15. CANADA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 16. CANADA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 17. MEXICO HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 18. MEXICO HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 19. GERMANY HYPODERMIC NEEDLES MARKET, 2014-2022($MILLION)
FIGURE 20. GERMANY HYPODERMIC NEEDLES MARKET, 2014-2022(MILLION UNITS)
FIGURE 21. FRANCE HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 22. FRANCE HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 23. UK HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 24. UK HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 25. ITALY HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 26. ITALY HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 27. SPAIN HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 28. SPAIN HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 29. RUSSIA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 30. RUSSIA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 31. REST OF EUROPE HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION)
FIGURE 32. REST OF EUROPE HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 33. JAPAN HYPODERMIC NEEDLES MARKET, 2014-2022($MILLION)
FIGURE 34. JAPAN HYPODERMIC NEEDLES MARKET, 2014-2022(MILLION UNITS)
FIGURE 35. CHINA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 36. CHINA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 37. AUSTRALIA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 38. AUSTRALIA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 39. INDIA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 40. INDIA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 41. SOUTH KOREA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 42. SOUTH KOREA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 43. TAIWAN HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 44. TAIWAN HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 45. INDONESIA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 46. INDONESIA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 47. THAILAND HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 48. THAILAND HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 49. REST OF ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 50. REST OF ASIA-PACIFIC HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 51. BRAZIL HYPODERMIC NEEDLES MARKET, 2014-2022($MILLION)
FIGURE 52. BRAZIL HYPODERMIC NEEDLES MARKET, 2014-2022(MILLION UNITS)
FIGURE 53. TURKEY HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 54. TURKEY HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 55. VENEZUELA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 56. VENEZUELA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 57. SAUDI ARABIA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 58. SAUDI ARABIA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 59. SOUTH AFRICA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 60. SOUTH AFRICA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 61. COLOMBIA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 62. COLOMBIA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 63. ARGENTINA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 64. ARGENTINA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 65. REST OF LAMEA HYPODERMIC NEEDLES MARKET, 2014-2022 ($MILLION)
FIGURE 66. REST OF LAMEA HYPODERMIC NEEDLES MARKET, 2014-2022 (MILLION UNITS)
FIGURE 67. BD: NET SALES, ($MILLION), (2014-2016)
FIGURE 68. BD: NET SALES, BY SEGMENT, 2016 (%)
FIGURE 69. BD: NET SALES, BY GEOGRAPHY, 2016 (%)
FIGURE 70. B BRAUN: NET REVENUE, 2013-2015 ($MILLION)
FIGURE 71. B BRAUN: NET REVENUE, BY SEGMENT (%)
FIGURE 72. B BRAUN: NET REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 73. CATALENT: NET REVENUE, (2013-2015)
FIGURE 74. CATALENT: NET REVENUE, BY SEGMENT, 2016 (%)
FIGURE 75. CATALENT: NET REVENUE, BY GEOGRAPHY, 2016 (%)
FIGURE 76. MEDTRONIC: NET REVENUE, 2013-2015, ($MILLION)
FIGURE 77. MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)
FIGURE 78. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)
FIGURE 79. SMITHS: NET REVENUE, 2014-2016, ($MILLION)
FIGURE 80. SMITHS: NET SALES, BY SEGMENT, 2016 (%)
FIGURE 81. SMITHS: NET SALES, BY GEOGRAPHY, 2016 (%)
FIGURE 82. TERUMO: NET REVENUE, 2014-2016, ($MILLION)
FIGURE 83. TERUMO: NET SALES, BY SEGMENT, 2016 (%)
FIGURE 84. TERUMO: NET SALES, BY GEOGRAPHY, 2016 (%)

Enquiry Before Buy